ℹ️ Compiled from public regulatory records · Last regulator revision: May 31, 2026🚩 Report this page
Sodium Fluoride
Active ingredient · 2 therapeutic classes
Sold as Hismile · Fluoride · DawnMist · Anticavity · Zap APF
US FDAGB MHRA
- Drug class
- Fluoride
- Availability
- Prescription and OTC
- Routes
- Dental, Oral, Topical, Buccal
- Markets covered
- 2
- Products on record
- 172
- FDA reports (12 mo)
- 246
Overview
Sodium Fluoride is an active pharmaceutical ingredient in the Fluoride group (A12CD). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 137 | May 31, 2026 |
| GB United Kingdom | MHRA | 35 | May 22, 2026 |
USUnited States· FDA
137 products
Uses
Uses Helps protect against cavities.
How to take
GBUnited Kingdom· MHRA
35 products
Uses
Prevention of dental caries in adolescents and adults, particularly amongst patients at risk from multiple caries (coronal and/or root caries).
How to take
Sources & citations
- [1]FDA DailyMed · 0ae98f28-7e78-43… · revised October 25, 2023 [PDF]
- [2]MHRA (UK) · PL000490057 · revised September 12, 2025
- [3]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.